Overview

Protective Effect of Sivelestat Sodium on ARDS in Patients With Sepsis Complicated With Respiratory Failure

Status:
Not yet recruiting

Trial end date:
2023-10-30

Target enrollment:

Participant gender:

Summary

Sivelestat sodium has been approved for use in patients with SIRS and ALI, but whether it can protect patients with sepsis with respiratory failure from developing ARDS remains unknown.The aim of this study was to determine whether sivelestat sodium has a protective effect on ARDS in patients with sepsis complicated with respiratory failure.

Phase:

Phase 3

Details

Lead Sponsor:

Southeast University, China

Treatments:

Sivelestat